Read + Share
Amedeo Smart
Independent Medical Education
Luo M, Zhang L, Yang C, Zhou B, et al. CXCL13 variant predicts pegylated-interferon alpha treatment response in HBeAg-positive chronic hepatitis B patients. J Med Virol 2023;95:e28963.PMID: 37470204
Email
LinkedIn
Facebook
Twitter
Privacy Policy